IMPEL PHARMACEUTICALS CEO Adrian Adams' 2021 pay falls 35% to $2.4M
IMPEL PHARMACEUTICALS reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
IMPEL PHARMACEUTICALS reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, three executives at IMPEL PHARMACEUTICALS received on average a compensation package of $2.2M, a 5% increase compared to previous year.
Average pay of disclosed executives at IMPEL PHARMACEUTICALS
Adrian Adams, Chief Executive Officer, received $2.4M in total, which decreased by 35% compared to 2020. 39% of Adams' compensation, or $933K, was in stock awards. Adams also received $431K in non-equity incentive plan, $529K in option awards, as well as $525K in salary.
Leonard Paolillo, Chief Commercial Officer, received a compensation package of $2.3M. 57% of the compensation package, or $1.3M, was in option awards.
John Leaman, Chief Financial & Business Officer, earned $2.1M in 2021, a 283% increase compared to previous year.
IMPEL PHARMACEUTICALS' fiscal year ends on April 26.
Related executives
You may also like
Source: SEC filing on April 26, 2022.